Fonte: Scientific Reports. Unidades: FMRP, ICB
Assuntos: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, LISOSSOMOS, PROTEÍNAS QUINASES, INIBIDORES DE ENZIMAS, MEDICAMENTO, MUTAÇÃO GENÉTICA
ABNT
MACEDO, Brunno Gilberto Santos et al. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia. Scientific Reports, v. 14, n. 1, p. 25 , 2024Tradução . . Disponível em: https://doi.org/10.1038/s41598-024-74168-z. Acesso em: 08 out. 2025.APA
Macedo, B. G. S., Melo, M. A. de, Pereira-Martins, D. A., Traina, F., & Machado Neto, J. A. (2024). Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia. Scientific Reports, 14( 1), 25 . doi:10.1038/s41598-024-74168-zNLM
Macedo BGS, Melo MA de, Pereira-Martins DA, Traina F, Machado Neto JA. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia [Internet]. Scientific Reports. 2024 ; 14( 1): 25 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-024-74168-zVancouver
Macedo BGS, Melo MA de, Pereira-Martins DA, Traina F, Machado Neto JA. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia [Internet]. Scientific Reports. 2024 ; 14( 1): 25 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-024-74168-z